Invion to be introduced at Rodman & Renshaw Annual Global Investment Conference

Australian drug development company Invion Limited (ASX:IVX) is pleased to announce that Managing Director and Chief Executive Officer Dr William Garner is scheduled to speak at the Rodman & Renshaw Annual Global Investment Conference on September 9-11, 2012, at the Waldorf Astoria hotel in New York, NY.

Dr Garner will be introducing Invion to a wide range of industry and investment professionals, describing the company’s vision, development plan and forthcoming milestones for its programs in the area of inflammatory and autoimmune diseases, including chronic bronchitis, asthma, smoking cessation and lupus.

The Invion presentation is scheduled for Tuesday, September 11, 2012 at 4.45pm (EDT).

Posted in ASX Releases